Insiders · Profile

Lundberg Sven Ante

Chief Scientific Officer at CRISPR Therapeutics. Filing since 24 Oct 2016. CIK 0001682126

Company

Date

Role

Action

Amount

Of holding

24 Oct 2016

Chief Scientific Officer

Bought

400

$5.60K

0.1%

1 decision on file.